Omeros (FRA:3O8) Long-Term Capital Lease Obligation : €16.64 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Omeros Long-Term Capital Lease Obligation?

Omeros's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €16.64 Mil.

Omeros's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (€18.85 Mil) to Sep. 2023 (€18.04 Mil) and declined from Sep. 2023 (€18.04 Mil) to Dec. 2023 (€16.64 Mil).

Omeros's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (€25.78 Mil) to Dec. 2022 (€21.17 Mil) and declined from Dec. 2022 (€21.17 Mil) to Dec. 2023 (€16.64 Mil).

Omeros Long-Term Capital Lease Obligation Historical Data

The historical data trend for Omeros's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omeros Long-Term Capital Lease Obligation Chart

Omeros Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

29.09

23.65

25.78

21.17

16.64

Omeros Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															21.17	19.88	18.85	18.04	16.64

Omeros (FRA:3O8) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Omeros Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Omeros's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Omeros (FRA:3O8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omeros Corp (FRA:3O8) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

OMER:USA 3O8:Germany

Address

201 Elliott Avenue West, Seattle, WA, USA, 98119

Website

https://www.omeros.com

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Omeros (FRA:3O8) Headlines

No Headlines